-transparent.png){kind=logo}
Twenty patients with a history of treatment-resistant obsessional neurosis underwent a 4-week clinical trial of chlorimipramine. Scores on the Psychiatric Questionnaire for Obsessive Compulsive Neurosis, the Leyton Obsessional Inventory, and 3 self-assessments indicated that although there was no significant change in obsessive ruminations, obsessive rituals, horrific temptations, or pervading doubt, there was a substantial significant improvement in the obsessive symptom item and severity of obsessions, as well as anxiety, depression, and phobia. Side effects were mild. The authors believe that chlorimipramine is the most promising treatment for obsessive-compulsive neurosis.
J Ananth, and
L Solyom, and
S Bryntwick, and
U Krishnappa
January 1975,
Current therapeutic research, clinical and experimental,
J Ananth, and
L Solyom, and
S Bryntwick, and
U Krishnappa
December 1989,
Canadian journal of psychiatry. Revue canadienne de psychiatrie,
J Ananth, and
L Solyom, and
S Bryntwick, and
U Krishnappa
October 1986,
Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
J Ananth, and
L Solyom, and
S Bryntwick, and
U Krishnappa
October 1986,
Zhonghua shen jing jing shen ke za zhi = Chinese journal of neurology and psychiatry,
J Ananth, and
L Solyom, and
S Bryntwick, and
U Krishnappa
August 1980,
The Journal of clinical psychiatry,
J Ananth, and
L Solyom, and
S Bryntwick, and
U Krishnappa
January 1985,
Indian journal of psychiatry,
J Ananth, and
L Solyom, and
S Bryntwick, and
U Krishnappa
May 1987,
Xianggang hu li za zhi. The Hong Kong nursing journal,
J Ananth, and
L Solyom, and
S Bryntwick, and
U Krishnappa
February 1978,
The Practitioner,
J Ananth, and
L Solyom, and
S Bryntwick, and
U Krishnappa
October 1959,
American journal of psychotherapy,
J Ananth, and
L Solyom, and
S Bryntwick, and
U Krishnappa
September 1990,
The Journal of clinical psychiatry,
